
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication
Kumudhini Preethi Haran, Agnes Hajduczki, Mary S. Pampusch, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 70
Kumudhini Preethi Haran, Agnes Hajduczki, Mary S. Pampusch, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 70
Showing 1-25 of 70 citing articles:
Chimeric Antigen Receptor T-Cells: An Overview of Concepts, Applications, Limitations, and Proposed Solutions
Alaa Alnefaie, Sarah Albogami, Yousif A. Asiri, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 74
Alaa Alnefaie, Sarah Albogami, Yousif A. Asiri, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 74
CXCR1 Expression to Improve Anti-Cancer Efficacy of Intravenously Injected CAR-NK Cells in Mice with Peritoneal Xenografts
Yu Yang Ng, Johan Chin-Kang Tay, Shu Wang
Molecular Therapy — Oncolytics (2019) Vol. 16, pp. 75-85
Open Access | Times Cited: 122
Yu Yang Ng, Johan Chin-Kang Tay, Shu Wang
Molecular Therapy — Oncolytics (2019) Vol. 16, pp. 75-85
Open Access | Times Cited: 122
Approval of First CAR-Ts: Have we Solved all Hurdles for ATMPs?
Diane Seimetz, Karl Heller, Jan Richter
Cell Medicine (2019) Vol. 11
Open Access | Times Cited: 86
Diane Seimetz, Karl Heller, Jan Richter
Cell Medicine (2019) Vol. 11
Open Access | Times Cited: 86
CD8+ T-Cell Response to HIV Infection in the Era of Antiretroviral Therapy
Federico Perdomo-Celis, Natalia A. Taborda, Marı́a Teresa Rugeles
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 77
Federico Perdomo-Celis, Natalia A. Taborda, Marı́a Teresa Rugeles
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 77
Cytolytic CD8 + T cells infiltrate germinal centers to limit ongoing HIV replication in spontaneous controller lymph nodes
David R. Collins, Julia Hitschfel, Jonathan M. Urbach, et al.
Science Immunology (2023) Vol. 8, Iss. 83
Open Access | Times Cited: 25
David R. Collins, Julia Hitschfel, Jonathan M. Urbach, et al.
Science Immunology (2023) Vol. 8, Iss. 83
Open Access | Times Cited: 25
Stem cell-derived CAR T cells show greater persistence, trafficking, and viral control compared to ex vivo transduced CAR T cells
Mayra A. Carrillo, Anjie Zhen, Wenli Mu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 4, pp. 1000-1015
Open Access | Times Cited: 11
Mayra A. Carrillo, Anjie Zhen, Wenli Mu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 4, pp. 1000-1015
Open Access | Times Cited: 11
A Portrait of CXCR5+ Follicular Cytotoxic CD8+ T cells
Di Yu, Lilin Ye
Trends in Immunology (2018) Vol. 39, Iss. 12, pp. 965-979
Closed Access | Times Cited: 71
Di Yu, Lilin Ye
Trends in Immunology (2018) Vol. 39, Iss. 12, pp. 965-979
Closed Access | Times Cited: 71
Engineered Cell-Based Therapeutics: Synthetic Biology Meets Immunology
Fabio Caliendo, Marina Dukhinova, Velia Siciliano
Frontiers in Bioengineering and Biotechnology (2019) Vol. 7
Open Access | Times Cited: 58
Fabio Caliendo, Marina Dukhinova, Velia Siciliano
Frontiers in Bioengineering and Biotechnology (2019) Vol. 7
Open Access | Times Cited: 58
Advances in Developing CAR T-Cell Therapy for HIV Cure
Jinxin Qi, Chengchao Ding, Xian Jiang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 56
Jinxin Qi, Chengchao Ding, Xian Jiang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 56
CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection
Mary S. Pampusch, Hadia M. Abdelaal, Emily K. Cartwright, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 2, pp. e1009831-e1009831
Open Access | Times Cited: 29
Mary S. Pampusch, Hadia M. Abdelaal, Emily K. Cartwright, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 2, pp. e1009831-e1009831
Open Access | Times Cited: 29
Engineering CAR T Cells to Target the HIV Reservoir
Wenli Mu, Mayra A. Carrillo, Scott G. Kitchen
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 40
Wenli Mu, Mayra A. Carrillo, Scott G. Kitchen
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 40
In vivo killing of primary HIV-infected cells by peripheral-injected early memory–enriched anti-HIV duoCAR T cells
Kim Anthony-Gonda, Alex Ray, Hang Su, et al.
JCI Insight (2022) Vol. 7, Iss. 21
Open Access | Times Cited: 28
Kim Anthony-Gonda, Alex Ray, Hang Su, et al.
JCI Insight (2022) Vol. 7, Iss. 21
Open Access | Times Cited: 28
Influence of Culture Conditions on Ex Vivo Expansion of T Lymphocytes and Their Function for Therapy: Current Insights and Open Questions
Harish Sudarsanam, Raymund Buhmann, Reinhard Henschler
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 25
Harish Sudarsanam, Raymund Buhmann, Reinhard Henschler
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 25
An angel or a devil? Current view on the role of CD8+ T cells in the pathogenesis of myasthenia gravis
Yong Peng, Huan Yang, Quan Chen, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Yong Peng, Huan Yang, Quan Chen, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Toward T Cell-Mediated Control or Elimination of HIV Reservoirs: Lessons From Cancer Immunology
Geetha Mylvaganam, Adrienne G. Yanez, Marcela V. Maus, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 39
Geetha Mylvaganam, Adrienne G. Yanez, Marcela V. Maus, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 39
CXCR5 guides migration and tumor eradication of anti-EGFR chimeric antigen receptor T cells
Guangchao Li, Jintao Guo, Yanfang Zheng, et al.
Molecular Therapy — Oncolytics (2021) Vol. 22, pp. 507-517
Open Access | Times Cited: 29
Guangchao Li, Jintao Guo, Yanfang Zheng, et al.
Molecular Therapy — Oncolytics (2021) Vol. 22, pp. 507-517
Open Access | Times Cited: 29
HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected Individuals
Julia Sung, Shabnum Patel, Matthew L. Clohosey, et al.
Molecular Therapy (2018) Vol. 26, Iss. 10, pp. 2496-2506
Open Access | Times Cited: 38
Julia Sung, Shabnum Patel, Matthew L. Clohosey, et al.
Molecular Therapy (2018) Vol. 26, Iss. 10, pp. 2496-2506
Open Access | Times Cited: 38
PD-1 blockade and vaccination provide therapeutic benefit against SIV by inducing broad and functional CD8 + T cells in lymphoid tissue
Sheikh Abdul Rahman, Bhrugu Yagnik, Alexander P. R. Bally, et al.
Science Immunology (2021) Vol. 6, Iss. 63
Open Access | Times Cited: 25
Sheikh Abdul Rahman, Bhrugu Yagnik, Alexander P. R. Bally, et al.
Science Immunology (2021) Vol. 6, Iss. 63
Open Access | Times Cited: 25
Deep Phenotypic Analysis of Blood and Lymphoid T and NK Cells From HIV+ Controllers and ART-Suppressed Individuals
Ashley F. George, Xiaoyu Luo, Jason Neidleman, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Ashley F. George, Xiaoyu Luo, Jason Neidleman, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
From natural defenders to therapeutic warriors: NK cells in HIV immunotherapy
Thessa Laeremans, A Janssens, Joeri L. Aerts
Immunotherapy (2025), pp. 1-13
Closed Access
Thessa Laeremans, A Janssens, Joeri L. Aerts
Immunotherapy (2025), pp. 1-13
Closed Access
Syncytial therapeutics: Receptor-specific and direct-to-cytosol biologic drug delivery mediated by measles fusion complex
Víctor García, Casim A. Sarkar, Brenda M. Ogle
Journal of Controlled Release (2025) Vol. 380, pp. 967-975
Closed Access
Víctor García, Casim A. Sarkar, Brenda M. Ogle
Journal of Controlled Release (2025) Vol. 380, pp. 967-975
Closed Access
Engineering of CD8 + T cells with an HIV-specific synthetic notch receptor to secrete broadly therapeutic antibodies for combining antiviral humoral and cellular immune responses
Lina Meng, Hongwei Zhao, Shuang Chang, et al.
mBio (2025)
Open Access
Lina Meng, Hongwei Zhao, Shuang Chang, et al.
mBio (2025)
Open Access
Early treatment and PD1 inhibition enhance HIV-specific functionality of follicular CD8+ T cells
Sina Rüeger, Eva Gruener, Danni Wang, et al.
JCI Insight (2025) Vol. 10, Iss. 7
Open Access
Sina Rüeger, Eva Gruener, Danni Wang, et al.
JCI Insight (2025) Vol. 10, Iss. 7
Open Access
Therapeutic Targeting of HIV Reservoirs: How to Give T Cells a New Direction
Hongbing Yang, Zoë Wallace, Lucy Dorrell
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 31
Hongbing Yang, Zoë Wallace, Lucy Dorrell
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 31
Rapid Transduction and Expansion of Transduced T Cells with Maintenance of Central Memory Populations
Mary S. Pampusch, Kumudhini Preethi Haran, Geoffrey T. Hart, et al.
Molecular Therapy — Methods & Clinical Development (2019) Vol. 16, pp. 1-10
Open Access | Times Cited: 28
Mary S. Pampusch, Kumudhini Preethi Haran, Geoffrey T. Hart, et al.
Molecular Therapy — Methods & Clinical Development (2019) Vol. 16, pp. 1-10
Open Access | Times Cited: 28